Understanding the factors that influence the airborne survival of viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in aerosols is important for identifying routes of transmission and the value of various mitigation strategies for preventing transmission. We present measurements of the stability of SARS-CoV-2 in aerosol droplets (∼5 to 10 µm equilibrated radius) over timescales spanning 5 s to 20 min using an instrument to probe survival in a small population of droplets (typically 5 to 10) containing ∼1 virus/droplet. Measurements of airborne infectivity change are coupled with a detailed physicochemical analysis of the airborne droplets containing the virus. A decrease in infectivity to ∼10% of the starting value was observable for SARS-CoV-2 over 20 min, with a large proportion of the loss occurring within the first 5 min after aerosolization. The initial rate of infectivity loss was found to correlate with physical transformation of the equilibrating droplet; salts within the droplets crystallize at relative humidities (RHs) below 50%, leading to a near-instant loss of infectivity in 50 to 60% of the virus. However, at 90% RH, the droplet remains homogenous and aqueous, and the viral stability is sustained for the first 2 min, beyond which it decays to only 10% remaining infectious after 10 min. The loss of infectivity at high RH is consistent with an elevation in the pH of the droplets, caused by volatilization of CO 2 from bicarbonate buffer within the droplet. Four different variants of SARS-CoV-2 were compared and found to have a similar degree of airborne stability at both high and low RH.
Bioaerosol emissions from wastewater treatment plants may pose adverse health impact on workers and nearby communities. To detect and characterise bioaerosol emissions from wastewater treatment plant (WWTP), a novel real-time bioaerosol sensor, Spectral Intensity Bioaerosol Sensor (SIBS) was employed at a WWTP and a background site. The SIBS records a range of data (size, shape, and fluorescence emission across 16 wavelength bands from 298 to 735 nm for two excitation wavelengths (285 nm and 370 nm)) on single particles in real time. Additionally, excitation-emission matrix (EEM) of wastewater samples obtained by a spectrofluorometer was compared with SIBS spectra from WWTP. The results showed that the average number concentrations of total particles (NT) and fluorescence particles (NF) were both higher at the WWTP (NT = 2.01 cm-3, NF = 1.13 cm-3) than the background site (NT = 1.79 cm-3, NF = 1.01 cm-3). The temporal variation of NF and NT was highly variable at the WWTP and the concentration peaks were consistent with on-site activities. Moreover, the time-resolved number-size distribution of fluorescent particles revealed the predominance of fine scale particles (<1 μm) and the time-series channel by channel number concentrations demonstrated the temporal variability of dominant bio-fluorophores. Furthermore, the overall and size-segregated fluorescence spectra at two sites were multimodal. In particular, the fluorescence intensity increases with increasing particle size in WWTP spectra, which is not present in the background spectra. In addition, the highly resolved SIBS fluorescence spectra were broadly similar to EEM of wastewater. These findings confirmed that the spectrally resolved fluorescence detected by SIBS is capable of providing reliable bio-fluorophores information of bioaerosol emissions generated from wastewater, thus holding the potential for better characterisation of bioaerosols in real time.
Respiratory pathogens can be spread though the transmission of aerosolised expiratory secretions in the form of droplets or particulates. Understanding the fundamental aerosol parameters that govern how such pathogens survive whilst airborne is essential to understanding and developing methods of restricting their dissemination. Pathogen viability measurements made using Controlled Electrodynamic Levitation and Extraction of Bioaerosol onto Substrate (CELEBS) in tandem with a comparative kinetics electrodynamic balance (CKEDB) measurements allow for a direct comparison between viral viability and evaporation kinetics of the aerosol with a time resolution of seconds. Here, we report the airborne survival of mouse hepatitis virus (MHV) and determine a comparable loss of infectivity in the aerosol phase to our previous observations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Through the addition of clinically relevant concentrations of mucin to the bioaerosol, there is a transient mitigation of the loss of viral infectivity at 40% RH. Increased concentrations of mucin promoted heterogenous phase change during aerosol evaporation, characterised as the formation of inclusions within the host droplet. This research demonstrates the role of mucus in the aerosol phase and its influence on short-term airborne viral stability.
Airborne transmission plays a significant role in the transmission of respiratory diseases such as COVID-19, for which the respiratory aerosol droplets are responsible for the transportation of potentially infectious pathogens. However, the aerosol physicochemical dynamics during the exhalation process are not well understood. The representativeness of respiratory droplet surrogates of exhaled aerosol and suspension media for aerosols currently used for laboratory studies remains debated. Here, we compare the evaporation kinetics and equilibrium thermodynamics of surrogate respiratory aerosol droplets including sodium chloride, artificial saliva (AS) and Dulbecco's modified Eagle's medium (DMEM) by using the Comparative Kinetics Electrodynamic Balance. The potential influences of droplet composition on aerosol hygroscopic response and phase behavior, and the influence of mucin are reported. The equilibrium hygroscopicity measurement was used to verify and benchmark the prediction of evaporation kinetics of complex solutions using the Single Aerosol Particle Drying Kinetics and Trajectory model. We show that the compositionally complex culture media which differs from sodium chloride and artificial saliva (mucin-free solutions). The DMEM evaporation dynamics contained three distinctive phases when drying at a range of humidities, including a semi-dissolved phase when evaporating at the environmental humidity range. The effect of mucin on droplet evaporation and phase behavior at low RH were compared between AS and DMEM solutions. In both cases, mucin delayed the crystallization time of the droplets, but it promoted phase change (from homogenous to semi-dissolved/spherical with inclusions) to occur at higher water activities.
29 August 2022 in Proceedings of the National Academy of Sciences
Objectives: In 2019–2020, four national recommendations were published in the United Kingdom to encourage use of low carbon inhalers. This study aimed to investigate whether these were associated with a change in primary care dispensing in England and to explore associations between geographical variation and clinical commissioning group (CCG) characteristics. Design: Ecological study using aggregated publicly available data. Setting: All CCGs in England (March 2016 to February 2021). Participants: not applicable Main outcome measures: Percentage of low carbon inhalers dispensed. Results: The percentage of low carbon inhalers dispensed was 26.3% in 2020–2021 (of 8.8 million inhalers). This decreased over the study period for short-acting beta-agonist (SABA), inhaled corticosteroid (ICS) and ICS+long-acting beta-agonist (LABA) inhalers. The same trend was seen for LABA and ICS+LABA+long-acting muscarinic antagonist inhalers from 2019. The SABA and ICS classes were less often dispensed as low carbon inhalers (⁓6% versus 35–45%). Interrupted time series analyses found slight increases in low carbon inhaler percentage in the SABA, LABA and ICS classes after April 2019, which were soon erased by the long-term trend. There was also geographical variation, with the north-west, Birmingham and London consistently dispensing more low carbon inhalers. The presence of advice on climate change in CCG formularies/guidelines, the prevalence of asthma and population age profile were associated with significant variation in low carbon inhaler percentage for some classes. Conclusions: The percentage of low carbon inhalers dispensed in England remains low and continues to decrease. Greater use of low carbon inhalers is achievable, but is more likely with locally implemented initiatives.